See more : Oxford Instruments plc (OXIG.L) Income Statement Analysis – Financial Results
Complete financial analysis of Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jiangxi Synergy Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Eo2 Société Anonyme (ALEO2.PA) Income Statement Analysis – Financial Results
- AG Mortgage Investment Trust, I (MITP) Income Statement Analysis – Financial Results
- Biogen Inc. (0R1B.L) Income Statement Analysis – Financial Results
- Area Quest Inc. (8912.T) Income Statement Analysis – Financial Results
- Baxter International Inc. (BTL.DE) Income Statement Analysis – Financial Results
Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jxsynergy.com
About Jiangxi Synergy Pharmaceutical Co., Ltd.
Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers APIs, liquid crystal compounds, and intermediates. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 722.14M | 719.91M | 592.13M | 435.42M | 413.06M | 267.12M | 296.72M | 250.08M | 274.81M | 212.57M | 141.56M | 104.62M |
| Cost of Revenue | 501.78M | 486.45M | 413.27M | 283.27M | 290.20M | 188.94M | 188.13M | 153.26M | 165.55M | 129.79M | 91.91M | 72.44M |
| Gross Profit | 220.36M | 233.45M | 178.85M | 152.15M | 122.85M | 78.19M | 108.59M | 96.81M | 109.26M | 82.79M | 49.65M | 32.18M |
| Gross Profit Ratio | 30.51% | 32.43% | 30.21% | 34.94% | 29.74% | 29.27% | 36.60% | 38.71% | 39.76% | 38.94% | 35.07% | 30.76% |
| Research & Development | 63.15M | 60.91M | 39.02M | 35.30M | 36.33M | 25.36M | 12.52M | 12.74M | 14.36M | 9.40M | 7.05M | 6.57M |
| General & Administrative | 7.02M | 4.79M | 5.42M | 3.80M | 5.37M | 13.44M | 4.29M | 3.76M | 5.79M | 3.85M | 17.01M | 15.16M |
| Selling & Marketing | 26.26M | 18.47M | 18.03M | 13.85M | 13.07M | 11.36M | 9.47M | 10.41M | 10.39M | 9.48M | 8.05M | 5.95M |
| SG&A | 32.14M | 23.26M | 23.44M | 17.65M | 18.45M | 24.80M | 13.76M | 14.17M | 16.18M | 13.33M | 25.07M | 21.11M |
| Other Expenses | 268.09K | 25.09M | 17.10M | 9.80M | 7.02M | 43.80K | 1.84M | 9.30M | 6.73M | 3.83M | 3.54M | 3.33M |
| Operating Expenses | 115.54M | 109.26M | 79.57M | 62.75M | 61.80M | 55.77M | 35.26M | 38.31M | 41.71M | 32.06M | 25.75M | 21.42M |
| Cost & Expenses | 617.32M | 595.72M | 492.84M | 346.02M | 352.00M | 244.71M | 223.39M | 191.58M | 207.26M | 161.84M | 117.66M | 93.86M |
| Interest Income | 17.01M | 2.89M | 1.95M | 568.73K | 161.27K | 94.59K | 327.84K | 184.66K | 175.32K | 35.26K | 5.93M | 3.93M |
| Interest Expense | 10.65M | 7.70M | 5.69M | 8.99M | 4.21M | 1.63K | 521.39K | 1.70M | 4.57M | 7.88M | 0.00 | 0.00 |
| Depreciation & Amortization | 69.39M | 66.88M | 51.58M | 52.33M | 42.77M | 23.86M | 20.77M | 2.91M | 15.27M | 12.61M | 7.90M | 5.32M |
| EBITDA | 192.54M | 181.48M | 146.08M | 139.72M | 99.06M | 50.19M | 96.24M | 72.72M | 80.84M | 65.95M | 23.90M | 10.76M |
| EBITDA Ratio | 26.66% | 26.39% | 25.88% | 32.27% | 25.43% | 19.89% | 32.72% | 35.76% | 33.63% | 31.42% | 16.86% | 10.57% |
| Operating Income | 112.23M | 106.33M | 88.34M | 78.25M | 51.68M | 26.28M | 72.76M | 58.39M | 65.85M | 41.63M | 15.97M | 5.73M |
| Operating Income Ratio | 15.54% | 14.77% | 14.92% | 17.97% | 12.51% | 9.84% | 24.52% | 23.35% | 23.96% | 19.59% | 11.28% | 5.48% |
| Total Other Income/Expenses | 268.09K | -182.74K | 1.00 | -6.73M | -3.83M | 14.54M | 1.84M | 9.12M | 6.73M | -4.42M | -4.42M | 3.17M |
| Income Before Tax | 112.50M | 106.15M | 88.34M | 78.06M | 51.68M | 26.33M | 74.60M | 67.51M | 72.58M | 45.46M | 19.51M | 8.90M |
| Income Before Tax Ratio | 15.58% | 14.74% | 14.92% | 17.93% | 12.51% | 9.86% | 25.14% | 27.00% | 26.41% | 21.39% | 13.78% | 8.50% |
| Income Tax Expense | 6.52M | 5.48M | 7.22M | 8.01M | 3.37M | 1.79M | 9.15M | 9.52M | 9.70M | 6.25M | 2.62M | 869.20K |
| Net Income | 105.98M | 100.67M | 81.12M | 70.05M | 48.31M | 24.53M | 65.46M | 58.00M | 62.88M | 39.21M | 16.88M | 8.03M |
| Net Income Ratio | 14.68% | 13.98% | 13.70% | 16.09% | 11.70% | 9.18% | 22.06% | 23.19% | 22.88% | 18.44% | 11.93% | 7.67% |
| EPS | 0.28 | 0.31 | 0.26 | 0.23 | 0.16 | 0.08 | 0.23 | 0.25 | 0.29 | 0.32 | 0.14 | 0.05 |
| EPS Diluted | 0.28 | 0.29 | 0.24 | 0.23 | 0.16 | 0.08 | 0.22 | 0.25 | 0.29 | 0.32 | 0.14 | 0.05 |
| Weighted Avg Shares Out | 380.36M | 326.43M | 308.75M | 309.39M | 308.69M | 308.95M | 289.32M | 230.40M | 219.47M | 146.34M | 146.34M | 146.34M |
| Weighted Avg Shares Out (Dil) | 380.39M | 346.18M | 337.62M | 309.56M | 311.57M | 312.33M | 291.13M | 230.40M | 219.51M | 146.34M | 146.34M | 146.34M |
Source: https://incomestatements.info
Category: Stock Reports